Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy
Angelini Ventures marks its first investment in the cardiovascular and gene therapy space – and first in Asia,…